Home › Type 1 Diabetes › NCT07663136

Finding Immune Nascent Type 1 Diabetes

Finding Immune Nascent Type 1 Diabetes (FIND T1D)

Who can join

Ages 1 to 99 · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Participant must be in Indiana Biobank
* Participant must be able to provide consent
* Ages 1-99 including pregnant women

Exclusion Criteria:

* Refusal to sign informed consent for home screening is exclusionary for the home screening portion of the study
* While other medical conditions are allowable prior diabetes diagnosis is exclusionary for home autoantibody screening

About the study

The goal of this clinical trial is to understand how many individuals who previously participated in the Indiana Biobank will return a type 1 diabetes home screening kit based upon different methods of recruitment communication. The main question it aims to answer is:

What form of recruitment communication is most effective for completing a type 1diabetes home screening kit?

Researchers will compare two types of recruitment contact: email and mail based communication (low-touch) versus phone contact and follow-up by a research team member (high-touch).

Participants will be contacted either via email/mail or by phone and asked if they want to complete a type 1 diabetes home screening kit.

What is being tested

• phone call (behavioral)
• email/mail (behavioral)

Sponsor: Indiana University · Participants: 3,800 · Started: Jul 28, 2026

Contact the study team

• Maureen Mullen Montagano · Phone: 317-274-7677
• Adarsh Viswanath · Phone: 317-278-5033

Official record on ClinicalTrials.gov — NCT07663136

Locations in the U.S.

Conditions

• Type 1 Diabetes

From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.